Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Berberine Suppresses SASP via RXRα/PPARγ/NEDD4 in Atheroscle
2026-07-24
This study elucidates how berberine inhibits senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. The mechanistic findings clarify how modulation of this pathway attenuates age-related vascular inflammation, suggesting new directions for cardiovascular disease research.
-
Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Redefining Fluoresce
2026-07-24
Explore how Cy5 Goat Anti-Mouse IgG (H+L) Antibody empowers next-generation immunoassays with unparalleled signal amplification and specificity. This article delves deep into the scientific mechanisms, practical advantages, and decision-making strategies for advanced fluorescence-based mouse IgG detection.
-
Crystal Violet Staining Solution: Optimizing Nuclear Stainin
2026-07-23
Crystal Violet Staining Solution streamlines nuclear staining dye workflows, enabling precise quantification and visualization in advanced cell assays. Its robust 2% alkaline formulation delivers reproducible results across colony formation, migration, and biofilm studies, empowering researchers to confidently interpret complex cellular dynamics.
-
USP36–Snail1 Axis Drives Ribosome Biogenesis in Cancer Stres
2026-07-23
This study uncovers how USP36 stabilizes nucleolar Snail1 under ribotoxic stress, thereby promoting ribosome biogenesis and cancer cell survival. The findings highlight a novel resistance mechanism in solid tumors and suggest targeting the JNK–USP36–Snail1 pathway may enhance the efficacy of ribosome-inhibiting therapies.
-
Biotin-Tyramide: Strategic Signal Amplification for Translat
2026-07-22
This thought-leadership article explores how Biotin-tyramide, a high-purity biotinylation reagent from APExBIO, is transforming proximity labeling and spatial proteomics. We blend mechanistic insight with strategic guidance, leverage cutting-edge findings on RAB GTPase interactomes, and offer practical workflow parameters for translational researchers seeking ultrasensitive, high-resolution biological mapping.
-
Psora 4: Redefining Kv1.3 Blocker Selectivity in Immune Rese
2026-07-22
Explore how Psora 4, a potent Kv1.3 blocker, advances T cell research by offering unprecedented selectivity and mechanistic insight for immunomodulation. This article reveals new evidence on channel subunit effects, bridging basic science with assay innovation.
-
Epacadostat (INCB024360): Precision IDO1 Inhibition in Immun
2026-07-21
Epacadostat (INCB024360) is a potent, selective oral IDO1 inhibitor that enables precise modulation of tryptophan catabolism. It restores T lymphocyte proliferation and is a benchmark tool in immuno-oncology research, especially in PD-1/PD-L1 checkpoint inhibitor combination studies.
-
Pentoxifylline Modulates T Cell Responses in Leishmania and
2026-07-21
The reference study demonstrates that pentoxifylline, a non-specific phosphodiesterase inhibitor, can downregulate pro-inflammatory T cell responses and reduce tissue damage in both Leishmania and HTLV-I infections. These findings strengthen the rationale for targeting TNF-α and related cytokines in the management of immune-mediated pathology in infectious diseases.
-
LL-37 and Truncated Peptides: Distinct Antibiofilm and Bioci
2026-07-20
Luo et al. (2017) dissect the differential biocidal and antibiofilm properties of the human host defense peptide LL-37 and its truncated mimetics, KE-18 and KR-12, against clinically relevant pathogens. Their findings reveal that truncated peptides can retain or surpass certain antimicrobial activities, offering targeted strategies for biofilm prevention and infection control.
-
Balsalazide Disodium: Protocol Optimization for IBD Research
2026-07-20
Balsalazide disodium dihydrate empowers inflammation research and preclinical IBD modeling by offering targeted, water-soluble anti-inflammatory action with robust activation in the colon. This guide delivers workflow enhancements, protocol parameters, and troubleshooting strategies rooted in recent evidence, enabling researchers to unlock reliable, translationally relevant results.
-
Pomalidomide (CC-4047): Genomic Precision in Myeloma Researc
2026-07-19
Explore how Pomalidomide (CC-4047) enables genomically-informed research in multiple myeloma. This article uniquely connects drug mechanism, cellular heterogeneity, and assay design for advanced hematological malignancy studies.
-
Isoprinosine in Research: Immunotherapy and Antiviral Workfl
2026-07-18
Isoprinosine (inosine pranobex) is a dual-action immunomodulatory and antiviral tool, offering robust inhibition of HHV-1 replication and immune enhancement with a favorable safety profile. This guide translates cutting-edge mechanistic insights and published protocols into actionable steps for maximizing experimental reliability in viral infection models.
-
Recombinant Mouse Macrophage Colony Stimulating Factor (M-CS
2026-07-17
This article addresses persistent laboratory challenges in macrophage viability, proliferation, and functional assays, focusing on SKU PM2021: Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag. Leveraging scenario-driven questions, we demonstrate how this reagent from APExBIO delivers data-backed reliability and sensitivity for translational research workflows.
-
Mastering Senescence Controls: Precision with Lysosomal β-Ga
2026-07-17
Explore how the Lysosomal β-Galactosidase Staining Kit empowers translational researchers to accurately delineate lysosomal enzyme activity, providing an essential control for senescence assays and translational oncology studies. This thought-leadership article bridges new mechanistic insights from recent cancer research with practical, workflow-focused guidance, highlighting strategic differentiation and protocol optimization.
-
BX795: Redefining PDK1 Inhibition for Precision Cancer Assay
2026-07-16
Explore how BX795, a potent PDK1 inhibitor, is revolutionizing the precision and interpretability of in vitro cancer drug assays. Learn why nuanced signaling modulation and advanced viability metrics are critical for next-generation research.